|
Baseline and end of study characteristics of the study population |
||||||
| Baseline |
End of study |
|||||
|
|
||||||
| Placebo (n = 74) |
Supplemented (n = 74) |
p-value |
Placebo (n = 74) |
Supplemented (n = 74) |
p-value |
|
|
|
||||||
| Age (months) |
35.2 ± 20 |
37.9 ± 20 |
0.72 |
- |
- |
- |
| Sex |
- |
|||||
| Female |
45.9% |
48.6% |
0.74 |
- |
- |
- |
| Antecedent |
||||||
| Reported children with fever episode on the previous year‡ |
78.30 (69–87.6) |
89.20 (82.1–96.3) |
0.041 |
- |
- |
- |
| Reported children with mosquito-net use on the previous night |
52.7 (41.4–64.0) |
56.7 (45.4–68.0) |
0.62 |
- |
- |
- |
| Anthropometry |
||||||
| Weight-for-height Z- score <-2.0 |
-0.73 ± 2.8 |
-0.82 ± 1.4 |
0.58 |
-1.10 ± 2 |
-1.03 ± 1.3 |
0.80 |
| Height-for-age Z- score <-2.0 |
-1.60 ± 2.3 |
-1.50 ± 2.0 |
0.77 |
-1.5 ± 2.4 |
-1.49 ± 1.7 |
0.97 |
| Weight-for-height Z- score <-2.0 (%) |
20.3 (11.2–29.4) |
13.5 (5.7–21.3) |
0.20 |
27.0 (17.0–37.0) |
23.0 (13.5–32.5) |
0.56 |
| Height-for-age Z- score <-2.0 (%) |
47.3 (36.0–58.6) |
40.5 (29.3–51.7) |
0.40 |
46.0 (34.7–57.3) |
35.0 (24.2–45.8) |
0.20 |
| Hematology |
||||||
| Mean (SD) hemoglobin (g/dl) |
9.4 ± 1.6 |
9.31 ± 2.3 |
0.75 |
10.21 ± 1.82 |
10.09 ± 1.97 |
0.70 |
| Anemia ≤ 7.0 g/dl‡ (%) |
5.4 (0.4–10.5) |
18.0 (9.3–26.7) |
0.020 |
5.4 (0.4–10.5) |
5.4 (0.4–10.5) |
0.71 |
| Malariometric indices |
||||||
| Positive P. falciparum |
61.0 (51–72) |
76.0 (66.-85) |
0.052 |
57.5% (46.2–68.8) |
42.0% (32.8–55.2) |
0.048 |
| Geometric mean density P. falciparum positive asexual forms/μl |
1444 (923–2259) |
1589 (1026–2459) |
0.38 |
1945 (1155–3275) |
1011 (647–1579) |
0.85 |
| Enlarged spleen |
61.0% (51–72) |
58.0% (47–69) |
0.73 |
57.0% (46–68) |
53.0% (42–64) |
0.62 |
|
Mean ± SD or % (CI 95%) ‡ p < 0.05 | ||||||
Zeba et al. Nutrition Journal 2008 7:7 doi:10.1186/1475-2891-7-7 |
||||||